查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363185

北美乳房重建市场规模、份额、趋势分析报告：按产品、形状、最终用途、地区和细分市场预测，2023-2030 年

North America Breast Reconstruction Market Size, Share & Trends Analysis Report By Product (Implant, Tissue Expander, Acellular Dermal Matrix), By Shape (Round Shape, Anatomical Shape), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

北美乳房重建市场的成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，北美乳房重建市场规模预计将达到 3.662 亿美元，2023 年至 2030 年年复合成长率为 6.8%。

这是由于该地区乳癌患者数量不断增加。例如，根据加拿大癌症协会 2019 年的数据，八分之一的女性将被诊断出罹患乳癌。此外，根据类似资讯来源，乳癌是加拿大第二大常见癌症。因此，加拿大乳癌患者数量的增加预计将推动北美乳房重建市场的发展。

此外，该地区的乳房重建手术数量正在增加。例如，根据整形外科檔案馆的数据，乳房重建术后乳房重建手术从2015年的19.4%增加到2018年的53.4%。同样，根据加拿大癌症协会的数据，加拿大五分之一的女性在乳房切除术后接受了乳房重建。因此，乳房重建手术数量的增加预计将推动北美乳房重建市场。

此外，各种宣传活动的开展也提高了妇女的意识。例如，乳房重建意识运动教育、参与并赋予妇女权力，让她们在乳癌诊断后就乳房重建做出正确的决定。

由于COVID-19的影响，北美乳房重建市场有所下滑。然而，大流行后，市场预计将出现显着的成长。预计在 COVID-19 期间推迟的择期手术（例如乳房植入手术）也将在 COVID-19 后期进行。此外，为了占领市场，许多公司正在采取各种策略，例如地理扩张、产品发布和联盟。

例如，2021 年 4 月，Sientra, Inc. 和 Butterfly Network 宣布建立策略伙伴关係，以改善乳房植入患者的诊断监测。预计这将有助于增强公司的安全状况，并得到其 Platinum20 保固计画的支持。因此，此类案例预计将推动 COVID-19 后北美乳房重建市场的发展。

北美乳房重建市场报告亮点

  • 依按产品划分，植体部门占最大市场占有率，2022年将达63.5%。然而，组织扩张器领域预计在预测期内以 6.9% 的年复合成长率年增长率发展最快。这是由于组织扩张器领域产品的进步。
  • 从形状来看，圆形扇形占比最大，2022年将达55.3%。然而，在预测期内，解剖形状预计将呈现最快的成长率，年复合成长率为 6.9%。
  • 根据最终用途，医院细分市场预计将在 2022 年以 55.3% 的份额主导市场。然而，美容诊所领域预计在预测期内将出现最高成长率，年复合成长率为 7.0%。这是由于北美地区美髮师数量不断增加。
  • 从区域来看，美国占市场主导地位，2022 年销售份额最大，达 74.4%。这是由于该国乳癌和乳房重建手术数量的增加。

目录

第1章调查方法与范围

第2章执行摘要

第3章北美乳房重建市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 北美乳房重建市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章北美乳房重建市场：产品评估与趋势分析

  • 北美乳房重建市场：重点
  • 北美乳房重建市场：2022年及2030年产品趋势及市场占有率分析
  • 注入
  • 组织扩张器
  • 去细胞真皮基质

第5章北美乳房重建市场：形状估计与趋势分析

  • 北美乳房重建市场：重点
  • 北美乳房重建市场：2022 年和 2030 年形状变化和市场占有率分析
  • 圆形
  • 解剖形状

第6章北美乳房重建市场：最终用途估计与趋势分析

  • 北美乳房重建市场：重点
  • 北美乳房重建市场：2022 年和 2030 年最终用途趋势和市场占有率分析
  • 医院
  • 美容诊所
  • 门诊手术中心

第7章北美乳房重建市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的北美乳房重建市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Mentor Worldwide LLC
    • AbbVie Inc.
    • Integra LifeSciences
    • Sientra, Inc.
    • Stryker
    • Establishment Labs
    • RTI Surgical
    • MTF Biologics
    • Surgical Innovation Associates
    • TELA Bio, Inc.
Product Code: GVR-2-68038-656-1

North America Breast Reconstruction Market Growth & Trends:

The North America breast reconstruction market size is expected to reach USD 366.2 million by 2030, registering a CAGR of 6.8% from 2023 to 2030, according to a new report by Grand View Research, Inc..This can be credited to the increase in number of breast cancer patients within this region. For instance, as per the Canadian Cancer Society 2019, one in eight females is expected to be diagnosed with breast cancer. Moreover, as per a similar source, breast cancer is the second most occurring cancer in Canada. Thus, the increasing number of breast cancer patients in Canada is predicted to boost the North America Breast Reconstruction market.

Moreover, the number of breast reconstruction surgery is also increasing in this region. For instance, as per the Archives of Plastic Surgery, post-mastectomy breast reconstruction surgery has increased from 19.4% in 2015 to 53.4% in 2018. Similarly, as per the Canadian Cancer Society, one in every five women in Canada goes under breast reconstruction post-mastectomy. Thus, a rise in the number of breast reconstruction surgery is anticipated to drive the North America breast reconstruction market.

Furthermore, the initiation of various awareness campaigns is leading to rising awareness among women. For instance, the Breast Reconstruction Awareness Campaign educates, engages & empowers females to take the right decision regarding breast reconstruction, post breast cancer diagnosis.

The North America breast reconstruction market witnessed a dip due to COVID-19. However, post-pandemic, the market is projected to have a significant growth rate. Elective surgeries such as breast augmentation, which were postponed during COVID-19, are expected to be held in the post-COVID-19 period. Moreover, to capture the market, many companies are entering into various strategies such as geographic expansion, product launches, and partnerships.

For instance, in April 2021, Sientra, Inc. and the Butterfly Network announced a strategic partnership to improve diagnostic surveillance of breast implant patients. This was expected to help the company to strengthen its safety profile, which was backed by the Platinum20 warranty program. Therefore, such instances are expected to drive the North America breast reconstruction market in the post-COVID-19 period.

North America Breast Reconstruction Market Report Highlights:

  • In terms of product, the implants segment held the largest market share of 63.5% in 2022 in the market. However, the tissue expander segment is expected to develop with the fastest growth rate of 6.9% CAGR, during the forecast period. This can be credited to the advancement in the products within the tissue expander segment
  • Based on shape, the round shape segment held the largest share of 55.3% in 2022 in the market. However, the anatomical shape is anticipated to witness the fastest growth rate of CAGR of 6.9% during the forecast period
  • Based on end-use, the hospital segment was expected to dominate the market with a 55.3% share during 2022. However, the cosmetology clinics segment is projected to witness the highest growth rate of 7.0% CAGR during the forecast period. This can be credited to the rising number of cosmetologists in the North America region.
  • Based on the region, the U.S. dominated the market with the largest revenue share of 74.4% in 2022. This can be credited to the increase in number of breast cancer & breast reconstruction procedures within this nation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Shape
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Shape outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. North America Breast Reconstruction Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. North America Breast Reconstruction Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. North America Breast Reconstruction Market: Product Estimates & Trend Analysis

  • 4.1. North America Breast Reconstruction Market: Key Takeaways
  • 4.2. North America Breast Reconstruction Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Implants
    • 4.3.1. Implants market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Silicone breast implants
      • 4.3.2.1. Silicone breast implants estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Saline breast implants
      • 4.3.3.1. Saline breast implants estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Tissue Expander
    • 4.4.1. Tissue expander market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Saline expander
      • 4.4.2.1. Saline expander estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Air tissue expander
      • 4.4.3.1. Air tissue expander estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Acellular Dermal Matrix
    • 4.5.1. Acellular dermal matrix market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. North America Breast Reconstruction Market: Shape Estimates & Trend Analysis

  • 5.1. North America Breast Reconstruction Market: Key Takeaways
  • 5.2. North America Breast Reconstruction Market: Shape Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Round Shape
    • 5.3.1. Round shape market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Anatomical Shape
    • 5.4.1. Anatomical shape market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. North America Breast Reconstruction Market: End Use Estimates & Trend Analysis

  • 6.1. North America Breast Reconstruction Market: Key Takeaways
  • 6.2. North America Breast Reconstruction Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Cosmetology Clinics
    • 6.4.1. Cosmetology clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. North America Breast Reconstruction Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. North America Breast Reconstruction Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Mentor Worldwide LLC
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. AbbVie Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Integra LifeSciences
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Sientra, Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Stryker
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Establishment Labs
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. RTI Surgical
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. MTF Biologics
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Surgical Innovation Associates
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. TELA Bio, Inc.
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America North America breast reconstruction market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America North America breast reconstruction market, by shape, 2018 - 2030 (USD Million)
  • Table 4 North America North America breast reconstruction market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America North America breast reconstruction market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. breast reconstruction market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. breast reconstruction market, by shape, 2018 - 2030 (USD Million)
  • Table 8 U.S. breast reconstruction market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada breast reconstruction market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada breast reconstruction market, by shape, 2018 - 2030 (USD Million)
  • Table 11 Canada breast reconstruction market, by end use, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 QFD modeling for market share assessment

Fig. 6 Market formulation & validation

Fig. 7 North America breast reconstruction: Market outlook

Fig. 8 North America breast reconstruction: Competitive insights

Fig. 9 Parent market outlook

Fig. 10 Related/ancillary market outlook

Fig. 11 Penetration and growth prospect mapping

Fig. 12 Industry value chain analysis

Fig. 13 North America breast reconstruction market driver impact

Fig. 14 North America breast reconstruction market restraint impact

Fig. 15 North America breast reconstruction market strategic initiatives analysis

Fig. 16 North America breast reconstruction market: Product movement analysis

Fig. 17 North America breast reconstruction market: Product outlook and key takeaways

Fig. 18 Implants market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 19 Silicone breast implants market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 20 Saline breast implants market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 21 Tissue expander market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 22 Saline expander market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 23 Air tissue expander market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 24 Acellular dermal matrix market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 25 North America breast reconstruction market: Shape movement analysis

Fig. 26 North America breast reconstruction market: Shape mode outlook and key takeaways

Fig. 27 Round shape market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 28 Anatomical shape market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 29 North America breast reconstruction market: End use movement analysis

Fig. 30 North America breast reconstruction market: End use outlook and key takeaways

Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 32 Cosmetology clinics market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 33 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 34 North America breast reconstruction market: Regional movement analysis

Fig. 35 North America breast reconstruction market: Regional outlook and key takeaways

Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)